Intravenous cell therapies for stroke

Osman Mir; Aditya P. Lal; Farhaan S. Vahidy; Kaushik Parsha; Sean I. Savitz

doi:10.1007/978-3-7091-1175-8_12

Intravenous cell therapies for stroke

Osman Mir, Aditya P. Lal, Farhaan S. Vahidy, Kaushik Parsha, Sean I. Savitz

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Stroke is the leading cause of disability and there are no proven therapies beyond the acute stage. Based on extensive animal data, there is mounting evidence that various types of cell therapies enhance recovery after stroke. We review intravenous delivery of cell therapies in animal studies and clinical trials. The intravenous delivery of various cell types has been reported to activate several different signaling mechanisms such as neuroprotective, immunomodulatory, and repair-enhancing processes in the brain. It has also been shown that although peripherally injected stem cells get trapped in the pulmonary circulation, they secrete paracrine factors and exert a profound effect on neural recovery in animal models. MSCs are also thought to interact within the reticuloendothelial system by inducing or inhibiting migration of different immune cells. This chapter also identifies major issues that need to be addressed going forward including optimal cell types of cells, patient populations, and time windows.

Original language	English (US)
Title of host publication	Cell-Based Therapies in Stroke
Publisher	Springer-Verlag Wien
Pages	171-179
Number of pages	9
ISBN (Electronic)	9783709111758
ISBN (Print)	9783709111741
DOIs	https://doi.org/10.1007/978-3-7091-1175-8_12
State	Published - Jan 1 2013

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-7091-1175-8_12

Cite this

@inbook{44385d7d1d124f96bee608f60cc2078f,

title = "Intravenous cell therapies for stroke",

abstract = "Stroke is the leading cause of disability and there are no proven therapies beyond the acute stage. Based on extensive animal data, there is mounting evidence that various types of cell therapies enhance recovery after stroke. We review intravenous delivery of cell therapies in animal studies and clinical trials. The intravenous delivery of various cell types has been reported to activate several different signaling mechanisms such as neuroprotective, immunomodulatory, and repair-enhancing processes in the brain. It has also been shown that although peripherally injected stem cells get trapped in the pulmonary circulation, they secrete paracrine factors and exert a profound effect on neural recovery in animal models. MSCs are also thought to interact within the reticuloendothelial system by inducing or inhibiting migration of different immune cells. This chapter also identifies major issues that need to be addressed going forward including optimal cell types of cells, patient populations, and time windows.",

author = "Osman Mir and Lal, {Aditya P.} and Vahidy, {Farhaan S.} and Kaushik Parsha and Savitz, {Sean I.}",

year = "2013",

month = jan,

day = "1",

doi = "10.1007/978-3-7091-1175-8_12",

language = "English (US)",

isbn = "9783709111741",

pages = "171--179",

booktitle = "Cell-Based Therapies in Stroke",

publisher = "Springer-Verlag Wien",

}

TY - CHAP

T1 - Intravenous cell therapies for stroke

AU - Mir, Osman

AU - Lal, Aditya P.

AU - Vahidy, Farhaan S.

AU - Parsha, Kaushik

AU - Savitz, Sean I.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Stroke is the leading cause of disability and there are no proven therapies beyond the acute stage. Based on extensive animal data, there is mounting evidence that various types of cell therapies enhance recovery after stroke. We review intravenous delivery of cell therapies in animal studies and clinical trials. The intravenous delivery of various cell types has been reported to activate several different signaling mechanisms such as neuroprotective, immunomodulatory, and repair-enhancing processes in the brain. It has also been shown that although peripherally injected stem cells get trapped in the pulmonary circulation, they secrete paracrine factors and exert a profound effect on neural recovery in animal models. MSCs are also thought to interact within the reticuloendothelial system by inducing or inhibiting migration of different immune cells. This chapter also identifies major issues that need to be addressed going forward including optimal cell types of cells, patient populations, and time windows.

AB - Stroke is the leading cause of disability and there are no proven therapies beyond the acute stage. Based on extensive animal data, there is mounting evidence that various types of cell therapies enhance recovery after stroke. We review intravenous delivery of cell therapies in animal studies and clinical trials. The intravenous delivery of various cell types has been reported to activate several different signaling mechanisms such as neuroprotective, immunomodulatory, and repair-enhancing processes in the brain. It has also been shown that although peripherally injected stem cells get trapped in the pulmonary circulation, they secrete paracrine factors and exert a profound effect on neural recovery in animal models. MSCs are also thought to interact within the reticuloendothelial system by inducing or inhibiting migration of different immune cells. This chapter also identifies major issues that need to be addressed going forward including optimal cell types of cells, patient populations, and time windows.

UR - http://www.scopus.com/inward/record.url?scp=84956737126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956737126&partnerID=8YFLogxK

U2 - 10.1007/978-3-7091-1175-8_12

DO - 10.1007/978-3-7091-1175-8_12

M3 - Chapter

AN - SCOPUS:84956737126

SN - 9783709111741

SP - 171

EP - 179

BT - Cell-Based Therapies in Stroke

PB - Springer-Verlag Wien

ER -

Intravenous cell therapies for stroke

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this